Data, disease and diplomacy: GISAID's innovative contribution to global health

Elbe, Stefan, Buckland‐Merrett, Gemma·2017·Global Challenges

Cited by (1,005)

Items 601–700 of 1,005

  1. Supramolecular Cylinders Target Bulge Structures in the 5′ UTR of the RNA Genome of SARS‐CoV‐2 and Inhibit Viral Replication**
    Larry Melidis, Harriet J. Hill, Nicholas J. Coltman, Scott P Davies, Kinga Winczura, Tasha Chauhan, James S. Craig, Aditya Garai, Catherine A. J. Hooper, Ross T. Egan et al. · 2021 · Angewandte Chemie International Edition
  2. Assessing the extent of community spread caused by mink-derived SARS-CoV-2 variants
    Liang Wang, Xavier Didelot, Yuhai Bi, George F. Gao · 2021 · The Innovation
  3. From Alpha to Zeta: Identifying Variants and Subtypes of SARS-CoV-2 Via Clustering
    Andrew Melnyk, Fatemeh Mohebbi, Sergey Knyazev, Bikram Sahoo, Roya Hosseini, Pavel Skums, Alex Zelikovsky, Murray Patterson · 2021 · Journal of Computational Biology
  4. Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study
    Roderick P Venekamp, Irene K Veldhuijzen, Karel G.M. Moons, Wouter van den Bijllaardt, Suzan D. Pas, Esther B Lodder, Richard Molenkamp, Zsὁfia Iglὁi, Constantijn Wijers, Claudy Oliveira dos Santos et al. · 2022 · BMC Medicine
  5. A rapid, specific, extraction-less, and cost-effective RT-LAMP test for the detection of SARS-CoV-2 in clinical specimens
    Francesco Elia Marino, Eric Proffitt, Eugene Joseph, Arun Manoharan · 2022 · PLoS ONE
  6. Molecular Dynamics and MM-PBSA Analysis of the SARS-CoV-2 Gamma Variant in Complex with the hACE-2 Receptor
    Maurizio Cavani, Walter Riofrío, Marcelino Arciniega · 2022 · Molecules
  7. Evolutionary history and introduction of SARS-CoV-2 Alpha VOC/B.1.1.7 in Pakistan through international travelers
    Asghar Nasir, Ali Raza Bukhari, Nídia Sequeira Trovão, Peter Thielen, Akbar Kanji, Syed Faisal Mahmood, Najia Karim Ghanchi, Zeeshan Ansar, Brian B. Merritt, Thomas S. Mehoke et al. · 2022 · Virus Evolution
  8. Impact of the COVID-19 Pandemic on International Tourism Income in Tourism Receiving Countries
    Bartosz Korinth · 2022 · Sustainability
  9. Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro
    Vu Thuy Khanh Le‐Trilling, Denise Mennerich, Corinna Schuler, Roman Sakson, Julia K. Lill, Siva Swapna Kasarla, Dominik Kopczynski, Stefan Loroch, Yulia Flores-Martinez, Benjamin Katschinski et al. · 2022 · BMC Biology
  10. Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity
    Daichao Wu, Grigory Aleksandrovich Efimov, Боголюбова Аполлинария Васильевна, Brian G. Pierce, Roy A. Mariuzza · 2023 · Journal of Biological Chemistry
  11. Introductions of Human-Origin Seasonal H3N2, H1N2 and Pre-2009 H1N1 Influenza Viruses to Swine in Brazil
    Caroline Tochetto, Dennis Maletich Junqueira, Tavis K. Anderson, Danielle Gava, Vanessa Haach, Maurício Egídio Cantão, Amy L. Vincent Baker, Rejane Schaefer · 2023 · Viruses
  12. Integrative Approach to Dissect the Drug Resistance Mechanism of the H172Y Mutation of SARS-CoV-2 Main Protease
    Joseph Clayton, Vinícius M. de Oliveira, Mohamed Fouad Ibrahim, Xinyuanyuan Sun, Paween Mahinthichaichan, Mingzhe Shen, Rolf Hilgenfeld, Jana Shen · 2023 · Journal of Chemical Information and Modeling
  13. Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity
    Yuan Chen, Georgina H. Mason, David Oliver Scourfield, Alexander Greenshields‐Watson, Tracey A. Haigh, Andrew Kelvin Sewell, Heather M. Long, Awen Gallimore, P.J. Rizkallah, Bruce J. MacLachlan et al. · 2023 · Cell Reports
  14. An interpretative review of the wastewater-based surveillance of the SARS-CoV-2: where do we stand on its presence and concern?
    Gayatri Gogoi, Sarangthem Dinamani Singh, Emon Kalyan, Devpratim Koch, Pronami Gogoi, Suman Kshattry, Hridoy Jyoti Mahanta, Md Imran, Rajesh Pandey, Pankaj Bharali · 2024 · Frontiers in Microbiology
  15. Abolished frameshifting for predicted structure-stabilizing SARS-CoV-2 mutants: implications to alternative conformations and their statistical structural analyses
    Abhishek Dey, Shuting Yan, Tamar Schlick A, Alain Laederach · 2024 · RNA
  16. V-pipe 3.0: a sustainable pipeline for within-sample viral genetic diversity estimation
    Lara Fuhrmann, Kim Philipp Jablonski, Ivan Topolsky, Aashil A. Batavia, Nico Borgsmüller, Pelin Icer Baykal, Matteo Carrara, Chaoran Chen, Arthur Dondi, Monica Dragan et al. · 2024 · GigaScience
  17. Mapping the genomic landscape & diversity of COVID-19 based on >3950 clinical isolates of SARS-CoV-2
    Hina Singh, Jasdeep Singh, Mohd Khubaib, Salma Jamal, Javaid Ahmad Sheikh, Sunil Kohli, Seyed E. Hasnain, Syed Asad Rahman · 2020 · The Indian Journal of Medical Research
  18. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections — New York City, March 2020
    Dena Bushman, Karen Ann Alroy, Sharon K. Greene, Page Keating, Amanda Wahnich, Don Weiss, Preeti Pathela, Christy Harrison, Jennifer L. Rakeman, Gayle Langley et al. · 2020 · MMWR Morbidity and Mortality Weekly Report
  19. The Impact of SARS-CoV-2 on the Human Immune System and Microbiome
    Chuxi Wang, Xin Zhou, Meng Wang, Xin Chen · 2020 · Infectious Microbes & Diseases
  20. COVID-19 outbreak in Malaysia: Decoding D614G mutation of SARS-CoV-2 virus isolated from an asymptomatic case in Pahang
    Aini Syahida Mat Yassim, Mohd Fazli Farida Asras, Ahmad Mahfuz Gazali, Martín Sebastián Marcial-Coba, Ummu Afeera Zainulabid, Hajar Fauzan Ahmad · 2021 · Materials Today Proceedings
  21. Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
    Tyler N. Starr, Nadine Czudnochowski, Fabrizia Zatta, Young‐Jun Park, Zhuoming Liu, Amin Addetia, Dora Pinto, Martina Beltramello, Patrick Hernandez, Allison J. Greaney et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Towards Understanding and Identification of Human Viral Co-Infections
    Hui Wu, Hangyu Zhou, Heng Zheng, Aiping Wu · 2024 · Viruses
  23. Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory
    Neta S. Zuckerman, Rakefet Pando, Efrat Dahan Bucris, Yaron Drori, Yaniv Lustig, Oran Erster, Orna Mor, Ella Mendelson, Michal Mandelboim · 2020 · Viruses
  24. The Evolving Faces of the SARS-CoV-2 Genome
    Maria Schmidt, Mamoona Arshad, Stephan H. Bernhart, Siras Hakobyan, Arsen Arakelyan, Henry Loeffler‐Wirth, Hans Binder · 2021 · Viruses
  25. Development of a Multiplex Tandem PCR (MT-PCR) Assay for the Detection of Emerging SARS-CoV-2 Variants
    Richard Hale, Peter Crowley, Samir Dervisevic, Lindsay J. Coupland, Penelope R. Cliff, Saidat A R T Ebie, Luke B. Snell, Joel Paul, Cheryl Williams, Paul Anthony Randell et al. · 2021 · Viruses
  26. A comprehensive protein design protocol to identify resistance mutations and signatures of adaptation in pathogens
    Aditya Kumar Padhi, Timir Tripathi · 2022 · Briefings in Functional Genomics
  27. The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic
    Youssef Ait Hamdan, Fatima El Amerany, Jacques Desbrières, Abdessadek Aghrinane, Hassane Oudadesse, Mohammed Rhazi · 2022 · Polymer Bulletin
  28. Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia
    Ruarai J. Tobin, James Gareth Wood, Duleepa Jayasundara, Grant E. Sara, Camelia R. Walker, Genevieve Elizabeth Martin, James M. McCaw, Freya M. Shearer, David J. Price · 2023 · BMC Infectious Diseases
  29. The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells
    Antonella Bugatti, Federica Filippini, Serena Messali, Marta Giovanetti, Cosetta Ravelli, Alberto Zani, Massimo Ciccozzi, Arnaldo Caruso, Francesca Caccuri · 2023 · Viruses
  30. A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study
    Nhi Thi Hong Nguyen, Tsong-Yih Ou, Lê Đức Huy, Chung‐Liang Shih, Yao-Mao Chang, Phan Thanh Phuc, Chung‐Chien Huang · 2023 · Frontiers in Public Health
  31. SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors
    Cecily Choy, Joseph Chen, Jiangyuan Li, D. Travis Gallagher, Jian Lü, Daichao Wu, Ainslee Zou, Humza Hemani, Beverly A. Baptiste, Emily Wichmann et al. · 2023 · Nature Communications
  32. Detection of H3N8 influenza A virus with multiple mammalian-adaptive mutations in a rescued Grey seal (Halichoerus grypus) pup
    Divya Venkatesh, Carlo Bianco, Alejandro Núñez, Rachael Collins, Darryl Thorpe, Scott M. Reid, Sharon M. Brookes, Steve C. Essen, Natalie McGinn, James Seekings et al. · 2020 · Virus Evolution
  33. Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level
    Malik Sallam, Azmi M. Mahafzah · 2021 · Pathogens
  34. Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans
    Scott Burkholz, Suman Pokhrel, Benjamin R. Kraemer, Daria Mochly‐Rosen, Richard T. Carback, Tom Hodge, Paul E. Harris, Serban Ciotlos, Lu Wang, C.v. Herst et al. · 2021 · Infection Genetics and Evolution
  35. SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans
    Tomokazu Konishi · 2021 · PLoS ONE
  36. CoronaHiT: High throughput sequencing of SARS-CoV-2 genomes
    Dave Baker, Alp Aydin, Thanh Le-Viet, Gemma L. Kay, Steven J. Rudder, Leonardo de Oliveira Martins, Ana P. Tedim, Anastasia Kolyva, María Díaz, Nabil-Fareed Alikhan et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  37. A phylogeny-based metric for estimating changes in transmissibility from recurrent mutations in SARS-CoV-2
    Damien Richard, Liam P. Shaw, Robert Lanfear, Russell B Corbett-Detig, Angie S. Hinrichs, Jakob McBroome, Yatish Turakhia, Mislav Acman, Christopher J. Owen, Cedric C.S. Tan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Comprehensive Genome Analysis of 6,000 USA SARS-CoV-2 Isolates Reveals Haplotype Signatures and Localized Transmission Patterns by State and by Country
    Li Shen, Jennifer Dien Bard, Jaclyn A. Biegel, Alexander Russell Judkins, Xiaowu Gai · 2020 · Frontiers in Microbiology
  39. Genome‐wide association analysis of COVID‐19 mortality risk in SARS‐CoV‐2 genomes identifies mutation in the SARS‐CoV‐2 spike protein that colocalizes with P.1 of the Brazilian strain
    Georg Hahn, Chloe M. Wu, Sanghun Lee, Sharon Marie Lutz, Surender Khurana, Lindsey Robert Baden, Sebastien Haneuse, Dandi Qiao, Julian Hecker, Dawn Lisa DeMeo et al. · 2021 · Genetic Epidemiology
  40. Development of an in silico multi-epitope vaccine against SARS-COV-2 by précised immune-informatics approaches
    Saad Al Zamane, Fahim Alam Nobel, Ruksana Akter Jebin, Mohammed A. Amin, Pratul Dipta Somadder, Nusrat Jahan Antora, Md. Imam Hossain, Mohammod Johirul Islam, Kawsar Ahmed, Mohammad Ali Moni · 2021 · Informatics in Medicine Unlocked
  41. Who Owns a Deadly Virus? Viral Sovereignty, Global Health Emergencies, and the Matrix of the International
    Stefan Elbe · 2022 · International Political Sociology
  42. Human-to-dog transmission of SARS-CoV-2, Colombia
    Ricardo Rivero, Evelin Garay, Yesica Botero, Hector Alejandro Serrano Coll, Bertha Gastelbondo, Marina Muñoz, Nathalia Ballesteros, Sergio Castañeda, Luz Helena Patiño, Juan David Ramírez et al. · 2022 · Scientific Reports
  43. Increased Frequency of Indels in Hypervariable Regions of SARS-CoV-2 Proteins—A Possible Signature of Adaptive Selection
    Arghavan Alisoltani, Lukasz Jaroszewski, Mallika Iyer, Arash Iranzadeh, Adam Godzik · 2022 · Frontiers in Genetics
  44. SARS-CoV-2 strain wars continues: Chemical and thermodynamic characterization of live matter and biosynthesis of Omicron BN.1, CH.1.1 and XBC variants
    Marko E. Popovic · 2023 · Microbial Risk Analysis
  45. Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA)
    Cheng-Wei Cheng, Chung‐Yi Wu, Szu-Wen Wang, Jiayan Chen, Chih‐Chuan Kung, Kuo‐Shiang Liao, Chi‐Huey Wong · 2023 · Proceedings of the National Academy of Sciences
  46. Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny
    Martin Hunt, Angie S. Hinrichs, Daniel Anderson, Lily Karim, Bethany L. Dearlove, Jeff Knaggs, Bede Constantinides, Philip William Fowler, Gillian Rodger, Teresa Street et al. · 2026 · Nature Methods
  47. Timely intervention and control of a novel coronavirus (COVID-19) outbreak at a large skilled nursing facility—San Francisco, California, 2020
    Ellora N. Karmarkar, Irin Blanco, Pauli N. Amornkul, Amie DuBois, Xianding Deng, Patrick K. Moonan, Beth L. Rubenstein, David A. Miller, Idamae Kennedy, Jennifer W. Yu et al. · 2020 · Infection Control and Hospital Epidemiology
  48. Molecular docking and dynamic simulation of conserved B cell epitope of SARS-CoV-2 glycoprotein Indonesian isolates: an immunoinformatic approach
    Fedik Abdul Rantam, Viol Dhea Kharisma, Christrijogo Sumartono Waloejo, Jusak Nugraha, Andi Yasmin Wijaya, Helen Susilowati, Suryo Kuncorojakti, Alexander Patera Nugraha · 2021 · F1000Research
  49. Forecasting emergence of COVID-19 variants of concern
    James Kyle Miller, Kimberly Elenberg, Artur W. Dubrawski · 2022 · PLoS ONE
  50. Covidex: An ultrafast and accurate tool for SARS-CoV-2 subtyping
    Marco Cacciabue, Pablo Aguilera, María Inés Gismondi, Oscar Alberto Taboga · 2022 · Infection Genetics and Evolution
  51. COVID-19 CG: Tracking SARS-CoV-2 mutations by locations and dates of interest
    Albert Tian Chen, Kevin Altschuler, Shing H. Zhan, Yujia A. Chan, Benjamin E. Deverman · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Large-scale population analysis of SARS-CoV-2 whole genome sequences reveals host-mediated viral evolution with emergence of mutations in the viral Spike protein associated with elevated mortality rates
    Carlos Farkas, Andy Mella, Jody J. Haigh · 2020 · medRxiv
  53. Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae
    Nusrat J Epsi, Josh G. Chenoweth, Paul W. Blair, David A Lindholm, Anuradha Ganesan, Tahaniyat Lalani, Alfred Glaze Smith, Rupal M. Mody, Milissa U. Jones, Rhonda E Colombo et al. · 2024 · The Journal of Infectious Diseases
  54. Novel imported clades accelerated the RSV surge in Beijing, China, 2023-2024
    Xiaofeng Wei, Liang Wang, Maozhong Li, Jianxun Qi, Lu Kang, Geng Hu, Cheng Gong, Chengcheng Wang, Yiting Wang, Fang Huang et al. · 2024 · Journal of Infection
  55. Variant analysis of SARS-CoV-2 genomes in the Middle East
    Khalid Mubarak Bindayna, Shane Crinion · 2021 · Microbial Pathogenesis
  56. Convergent evolution of SARS-CoV-2 in human and animals
    Hangyu Zhou, Chengyang Ji, Hang Fan, Na Han, Xiaofeng Li, Aiping Wu, Cheng‐Feng Qin · 2021 · Protein & Cell
  57. Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance
    Jia Zou, Li Li, Peiyi Zheng, Wenhua Liang, Siyi Hu, Shuaixiang Zhou, Yanqun Wang, Jincun Zhao, Daopeng Yuan, Lu Liu et al. · 2022 · Journal of Clinical Investigation
  58. A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs
    Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, Govindasamy Agoramoorthy · 2022 · GeroScience
  59. Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: From alpha to Omicron
    Choo Yee Yu, Sie Yeng Wong, Nancy Woan Charn Liew, Narcisse Mary Sither Joseph, Zunita Zakaria, Nurulfiza Mat Isa, Hui Jen Soe, Rachna Kairon, Syafinaz Amin Nordin, Hui‐Yee Chee · 2022 · Frontiers in Medicine
  60. A COVID-19 model incorporating variants, vaccination, waning immunity, and population behavior
    Zachary LaJoie, Thomas R. Usherwood, Shailen G. Sampath, Vikas Srivastava · 2022 · Scientific Reports
  61. Wastewater surveillance uncovers regional diversity and dynamics of SARS-CoV-2 variants across nine states in the USA
    Rafaela Salgado Fontenele, Yi‐Yan Yang, Erin M. Driver, Arjun Magge, Simona J. Kraberger, Joy M. Custer, Keith Dufault‐Thompson, Erin Cox, Melanie Engstrom Newell, Arvind Varsani et al. · 2023 · The Science of The Total Environment
  62. Quantification of SARS-CoV-2 spike protein expression from mRNA vaccines using isotope dilution mass spectrometry
    William J.H. Sutton, Paul J. Branham, Yulanda M. Williamson, Hans C. Cooper, Fabio N. Najjar, Carrie L. Pierce, John Robert Barr, Tracie L. Williams · 2023 · Vaccine
  63. Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis
    Shuyu Deng, Ling Guo, Cheryl Cohen, Adam Meijer, Jocelyn Moyes, Siripat Pasittungkul, Yong Poovorawan, Anne C. Teirlinck, Michiel van Boven, Nasamon Wanlapakorn et al. · 2023 · The Journal of Infectious Diseases
  64. Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023
    Il‐Hwan Kim, Jin Sun No, Jeong-Ah Kim, Ae Kyung Park, Hyeokjin Lee, Jeong‐Min Kim, Nam‐Joo Lee, Chi-Kyeong Kim, Chae Young Lee, SangHee Woo et al. · 2023 · Virology
  65. Navigating the Landscape: A Comprehensive Review of Current Virus Databases
    Muriel Ritsch, Noriko A. Cassman, Shahram Saghaei, Manja Marz · 2023 · Viruses
  66. The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection-Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures
    Jo L. Wilson, Elgin Henry Akin, Ruifeng Zhou, Anne Jedlicka, Amanda Dziedzic, Hsuan Liu, Katherine Fenstermacher, Richard Eric Rothman, Andrew S Pekosz · 2023 · Viruses
  67. Biophysical principles predict fitness of SARS-CoV-2 variants
    Dianzhuo Wang, Marian Huot, Vaibhav Mohanty, Eugene I. Shakhnovich · 2024 · Proceedings of the National Academy of Sciences
  68. Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017–2018 Season and Reveal Age‐Associated Differences in Susceptibility and Antibody‐Binding Specificity
    Kangchon Kim, Marcos C. Vieira, Sigrid Gouma, Madison E. Weirick, Scott E. Hensley, Sarah E. Cobey · 2024 · Influenza and Other Respiratory Viruses
  69. Genomic signatures and host adaptation of H5N1 clade 2.3.4.4b: A call for global surveillance and multi-target antiviral strategies
    Guangxu Zhang, Yuren Shi, Haoyu Ge, Yuanzhou Wang, Lu Lu, Shibo Jiang, Qian Wang · 2025 · Current Research in Microbial Sciences
  70. Computational Approaches and Challenges to Developing Universal Influenza Vaccines
    Xueting Qiu, Venkata R. S. K. Duvvuri, Justin Bahl · 2019 · Vaccines
  71. Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity
    Evan K Bolyen, Matthew R. Dillon, Nicholas A. Bokulich, Jason T. Ladner, Brendan B. Larsen, Crystal M. Hepp, Darrin Lemmer, Jason W. Sahl, Andrew Sanchez, Chris Holdgraf et al. · 2020 · F1000Research
  72. Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells
    Kennosuke Wada, Yoshiko Wada, Toshimichi Ikemura · 2020 · Gene
  73. Analysis of SARS‐CoV‐2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis
    María Teresa Hernández‐Huerta, Laura Perez-Campos Mayoral, Carlos Romero Díaz, Margarito Martínez Cruz, Gabriel Mayoral Andrade, Luis Manuel Sánchez Navarro, María del Socorro Pina-Canseco, Elí Cruz Parada, Ruth Martínez Cruz, Eduardo Pérez‐Campos Mayoral et al. · 2020 · Journal of Medical Virology
  74. Evaluation of virucidal activity of residual quaternary ammonium-treated surfaces on SARS-CoV-2
    Alexander Gabriel Caschera, Julie McAuley, Youry Kim, Damian F. J. Purcell, Jasper Rymenants, Daniel A. Foucher · 2021 · American Journal of Infection Control
  75. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants
    Efi Makdasi, Anat Zvi, Ron Alcalay, Tal Noy-Porat, Eldar Peretz, Adva Mechaly, Yinon Levy, Eyal Epstein, Theodor Chitlaru, Ariel Tennenhouse et al. · 2021 · Cell Reports
  76. Clinical Performance Characteristics of the Swift Normalase Amplicon Panel for Sensitive Recovery of Severe Acute Respiratory Syndrome Coronavirus 2 Genomes
    Lasata Shrestha, Michelle J. Lin, Hong Jian Xie, Margaret G. Mills, Shah A. Mohamed Bakhash, Vinod P. Gaur, Robert J. Livingston, Jared Castor, Emily A. Bruce, Jason Botten et al. · 2022 · Journal of Molecular Diagnostics
  77. In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3′-UTR
    María Asunción Barreda-Manso, Manuel Nieto‐Díaz, Altea Soto, Teresa Muñoz‐Galdeano, David Reigada, Rodrigo M. Maza · 2021 · International Journal of Molecular Sciences
  78. Computational Strategies to Combat COVID-19: Useful Tools to Accelerate SARS-CoV-2 and Coronavirus Research
    Franziska Hufsky, Kevin Lamkiewicz, Alexandre Almeida, Abdel Aouacheria, Cecilia N. Arighi, Alex G. Bateman, Jan Baumbach, Niko Beerenwinkel, Christian Brandt, Marco Cacciabue et al. · 2020 · Preprints.org
  79. Computational analysis of the effect of SARS-CoV-2 variant Omicron Spike protein mutations on dynamics, ACE2 binding and propensity for immune escape
    Natália Teruel, Matthew R. Crown, Matthew Bashton, Rafaël Najmanovich · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Vaccinia virus vaccination is expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus
    Syed Faraz Ahmed, Muhammad Saqib Sohail, Ahmed Abdul Quadeer, Matthew R. McKay · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Advancing the understanding and management of Mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies
    Rima Hajjo, Osama H. Abusara, Dima A. Sabbah, Sanaa K. Bardaweel · 2025 · BMC Infectious Diseases
  82. Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey
    Ayşe Banu Demir, Domenico Benvenuto, Hakan Abacıoğlu, Silvia Angeletti, Massimo Ciccozzi · 2020 · TURKISH JOURNAL OF BIOLOGY
  83. Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
    Sarah C. Brüningk, Juliane Klatt, Madlen Stange, Alfredo Mari, Myrta Brunner, Tim C. Roloff, Helena M. B. Seth-Smith, Michael Schweitzer, Karoline Leuzinger, Kirstine K. Søgaard et al. · 2022 · Virus Evolution
  84. Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America
    Elena Quinonez, Majid Vahed, Abdolrazagh Hashemi Shahraki, Mehdi Seyed Mirsaeidi · 2021 · Viruses
  85. Molecular characterization of SARS-CoV-2 from Bangladesh: implications in genetic diversity, possible origin of the virus, and functional significance of the mutations
    M M Rahman, Shirmin Bintay Kader, S M Shahriar Rizvi · 2021 · Heliyon
  86. Wave-wise comparative genomic study for revealing the complete scenario and dynamic nature of COVID-19 pandemic in Bangladesh
    Ishtiaque Ahammad, Mohammad Uzzal Hossain, Anisur Rahman, Zeshan Mahmud Chowdhury, Arittra Bhattacharjee, Keshob Chandra Das, Chaman Ara Keya, M. Salimullah · 2021 · PLoS ONE
  87. The effect of human vaccination behaviour on strain competition in an infectious disease: An imitation dynamic approach
    Aniruddha Deka, Samit K. Bhattacharyya · 2021 · Theoretical Population Biology
  88. A Qualitative RT-PCR Assay for the Specific Identification of the SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern
    Philippe Corbisier, Mauro Petrillo, Antonio Marchini, Maddalena Querci, Gerhard Buttinger, Meriem Bekliz, Katja Spieß, Charlotta Polacek, Anders Fomsgaard, Guy Van den Eede · 2022 · Journal of Clinical Virology
  89. A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa
    Mohammad Reza Rahbar, Shaden M. H. Mubarak, Anahita Hessami, Bahman Khalesi, Navid Pourzardosht, Saeed Khalili, Kobra Ahmadi Zanoos, Abolfazl Jahangiri · 2022 · Scientific Reports
  90. Mathematical modeling of the impact of Omicron variant on the COVID-19 situation in South Korea
    Jooha Oh, Catherine Apio, Taesung Park · 2022 · Genomics & Informatics
  91. D3AI-Spike: A deep learning platform for predicting binding affinity between SARS-CoV-2 spike receptor binding domain with multiple amino acid mutations and human angiotensin-converting enzyme 2
    Jiaxin Han, Tingting Liu, Xinben Zhang, Yanqing Yang, Yulong Shi, Jintian Li, Minfei Ma, Weiliang Zhu, Likun Gong, Zhijian Xu · 2022 · Computers in Biology and Medicine
  92. Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysis
    Margaret L. Lind, Alexander James Robertson, Júlio Dos Santos Silva, Frederick J. Warner, Andreas C. Coppi, Nathan D. Price, Chelsea Duckwall, Peri Sosensky, Eréndira C. Di Giuseppe, Ryan Borg et al. · 2022 · PLoS Medicine
  93. SARS‐CoV‐2 Non-structural protein 1(NSP1) mutation virulence and natural selection: Evolutionary trends in the six continents
    Samira Salami Ghaleh, Karim Rahimian, Mohammadamin Mahmanzar, Bahar Mahdavi, Samaneh Tokhanbigli, Mahsa Mollapour Sisakht, Amin Farhadi, Mahsa Mousakhan Bakhtiari, Donna Lee Kuehu, Youping Deng · 2022 · Virus Research
  94. Structural analysis of receptor engagement and antigenic drift within the BA.2 spike protein
    James W. Saville, Dhiraj Mannar, Xing Quan Zhu, Alison Berezuk, Spencer CHOLAK, Katherine R. Tuttle, Faezeh Vahdati Hassani, Sriram Subramaniam · 2023 · Cell Reports
  95. SARS-CoV-2 Affects Both Humans and Animals: What Is the Potential Transmission Risk? A Literature Review
    Antonio Santaniello, Giuseppe Perruolo, Serena Cristiano, Ayewa Lawoe Agognon, Serena Cabaro, Alessia Amato, Ludovico Dipineto, Luca Borrelli, Pietro Formisano, Alessandro Fioretti et al. · 2023 · Microorganisms
  96. SARS-CoV-2 Infection Dynamics in the Pittsburgh Zoo Wild Felids with Two Viral Variants (Delta and Alpha) during the 2021–2022 Pandemic in the United States
    Deepanker Tewari, Ryan Miller, J. Livengood, Le-Yi Wang, M. Killian, Felipe Bustamante, Candy Kessler, Nagaraja R. Thirumalapura, K. Terio, M. Torchetti et al. · 2023 · Animals
  97. Regional Transmission and Reassortment of 2.3.4.4b Highly Pathogenic Avian Influenza (HPAI) Viruses in Bulgarian Poultry 2017/18
    Divya Venkatesh, Adam Brouwer, Richard Ellis, Gabriela V. Goujgoulova, James Seekings, Ian Hay Brown, Nicola S. Lewis · 2020 · Viruses
  98. Viral Sovereignty or Sequence Etiquette? Asian Science, Open Data, and Knowledge Control in Global Virus Surveillance
    Lyle Fearnley · 2020 · East Asian Science Technology and Society An International Journal
  99. Geographical reconstruction of the SARS‐CoV‐2 outbreak in Lombardy (Italy) during the early phase
    Valeria Micheli, Sara Giordana Rimoldi, Francesca Romeri, Francesco Comandatore, Alessandro Mancon, Anna Gigantiello, Matteo Perini, Davide Mileto, Cristina Pagani, Alessandra Vernaglia Lombardi et al. · 2020 · Journal of Medical Virology
  100. On the Application of Advanced Machine Learning Methods to Analyze Enhanced, Multimodal Data from Persons Infected with COVID-19
    Wenhuan Zeng, Anupam Gautam, Daniel H. Huson · 2021 · Computation